Zepp Health Corporation’s SEC filings document a foreign private issuer whose American depositary shares each represent sixteen Class A ordinary shares. The company files current reports on Form 6-K and annual reporting on Form 20-F covering its smart wearable and health technology business, including Amazfit-branded products and the Zepp Digital Management Platform.
The filings and exhibits record unaudited operating results, revenue and margin commentary, cash, inventory and loan balances, product launches, capital-structure actions, risk factors, governance matters and ADR-related disclosure. They also provide formal disclosure around periodic results releases and other material information furnished by the company to U.S. markets.
Zepp Health Corporation Form 144 reports a proposed sale of 44,000 Class A ordinary shares (American depositary shares representing underlying Class A shares) with an aggregate market value of $411,070.00. The shares represent a small portion of the company's outstanding stock of 114,776,364 shares and are planned to be sold on the NYSE with an approximate sale date of 09/04/2025. The filer acquired the securities on 02/12/2018 through stock options that vested on that date. The filing states there were no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Zepp Health Corporation (ZEPP) filing a Form 144 notifies a proposed sale of 1,745 ADRs representing American depositary shares, with an aggregate market value of $60,656.20. The ADRs trade on the NYSE and the filing lists an approximate sale date of 08/27/2025. The securities were acquired through the vesting of restricted share units from Zepp Health between March 2018 and February 2020, and no sales by the holder in the past three months were reported.
Amendment No. 7 to Schedule 13G discloses that FIL Limited, Pandanus Partners, L.P. and Pandanus Associates, Inc. have completely exited their position in Zepp Health Corp (symbol ZEPP). As of the event date 31 Jul 2025, the group reports 0 Class A common shares (CUSIP CIB882000), equating to 0.0 % of the outstanding class. Consequently, the filers now fall below the 5 % reporting threshold. All voting and dispositive powers are reported as 0, and the certification confirms the securities were held in the ordinary course, not to influence control. The filing is signed 06 Aug 2025 by Richard Bourgelas under powers of attorney for each entity.
Allspring Global Investments Holdings, LLC has filed Amendment No. 7 to Schedule 13G declaring its current ownership in Zepp Health Corp (symbol ZEPP) as of 30 June 2025.
- Shares owned: 9,757,152 American Depositary Receipts (ADRs).
- Ownership percentage: 8.7 % of the outstanding ADR class, exceeding the 5 % reporting threshold.
- Voting/dispositive power: Sole voting power and sole dispositive power over the entire position; no shared power reported.
- Holder classification: Designated as a Holding Company/Control person (Item 3 — HC).
- Stake origin: Securities are held for clients of subsidiaries Allspring Global Investments, LLC and Allspring Funds Management, LLC; no single client holds more than 5 % of the class.
- Intent statement: Filing certifies the position was acquired in the ordinary course of business and not to influence control of Zepp Health.
- Signatories & dates: Event date 06-30-2025; filing signed by Senior Compliance Manager Jennifer Grunberg on 07-14-2025.
This disclosure signals a sizeable passive institutional position in Zepp Health, potentially viewed by the market as a vote of confidence in the company’s prospects without implying activist intentions.